2-[[4-[4-amino-7-[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]-6-methylpyrrolo[2,3-d]pyrimidin-5-yl]benzoyl]amino]-N-[[[(E)-4-[(3R)-3-[4-amino-6-methyl-5-[4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-4-oxobut-2-enyl]-cyclopropylamino]methyl]pyridine-4-carbonitrilium
C64H65F3N17O4+ — CID 147122248
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[4-[4-amino-7-[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]-6-methylpyrrolo[2,3-d]pyrimidin-5-yl]benzoyl]amino]-N-[[[(E)-4-[(3R)-3-[4-amino-6-methyl-5-[4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-4-oxobut-2-enyl]-cyclopropylamino]methyl]pyridine-4-carbonitrilium
2-[[4-[4-amino-7-[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]-6-methylpyrrolo[2,3-d]pyrimidin-5-yl]benzoyl]amino]-N-[[[(E)-4-[(3R)-3-[4-amino-6-methyl-5-[4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-4-oxobut-2-enyl]-cyclopropylamino]methyl]pyridine-4-carbonitrilium (PubChem CID 147122248) has the molecular formula C64H65F3N17O4+ and a molecular weight of 1193.33 g/mol. Its IUPAC name is 2-[[4-[4-amino-7-[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]-6-methylpyrrolo[2,3-d]pyrimidin-5-yl]benzoyl]amino]-N-[[[(E)-4-[(3R)-3-[4-amino-6-methyl-5-[4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-4-oxobut-2-enyl]-cyclopropylamino]methyl]pyridine-4-carbonitrilium.
Molecular Properties
| Compound Name | 2-[[4-[4-amino-7-[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]-6-methylpyrrolo[2,3-d]pyrimidin-5-yl]benzoyl]amino]-N-[[[(E)-4-[(3R)-3-[4-amino-6-methyl-5-[4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-4-oxobut-2-enyl]-cyclopropylamino]methyl]pyridine-4-carbonitrilium |
|---|---|
| PubChem CID | 147122248 |
| Molecular Formula | C64H65F3N17O4+ |
| Molecular Weight | 1193.33 g/mol |
| Exact Mass | 1192.54 |
| IUPAC Name | 2-[[4-[4-amino-7-[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]-6-methylpyrrolo[2,3-d]pyrimidin-5-yl]benzoyl]amino]-N-[[[(E)-4-[(3R)-3-[4-amino-6-methyl-5-[4-[[4-(trifluoromethyl)-2-pyridinyl]carbamoyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-4-oxobut-2-enyl]-cyclopropylamino]methyl]pyridine-4-carbonitrilium |
| SMILES | Cc1c(-c2ccc(C(=O)Nc3cc(C#[N+]CN(C/C=C/C(=O)N4CC[C@@H](n5c(C)c(-c6ccc(C(=O)Nc7cc(C(F)(F)F)ccn7)cc6)c6c(N)ncnc65)C4)C4CC4)ccn3)cc2)c2c(N)ncnc2n1[C@@H]1CCN(C(=O)/C=C/CN(C)C2CC2)C1 |
| InChI | InChI=1S/C64H64F3N17O4/c1-38-54(56-58(68)73-35-75-60(56)83(38)48-22-28-80(33-48)52(85)6-4-26-79(3)46-16-17-46)41-8-12-43(13-9-41)62(87)77-50-30-40(20-24-71-50)32-70-37-82(47-18-19-47)27-5-7-53(86)81-29-23-49(34-81)84-39(2)55(57-59(69)74-36-76-61(57)84)42-10-14-44(15-11-42)63(88)78-51-31-45(21-25-72-51)64(65,66)67/h4-15,20-21,24-25,30-31,35-36,46-49H,16-19,22-23,26-29,33-34,37H2,1-3H3,(H5-,68,69,71,72,73,74,75,76,77,78,87,88)/p+1/b6-4+,7-5+/t48-,49-/m1/s1 |
| InChIKey | ZHCQORZUHBXVTF-SBFFDMGWSA-O |
| XLogP | 9.16 |
| TPSA | 248.90 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 88 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1193.33 |
| LogP ≤ 5 | 9.16 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 147122248 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.